Literature DB >> 1999349

A novel MHC class I-related molecule expressed on mouse thymic stroma cells and mature lymphocytes.

K Mori1, K Hirata, M Kawabuchi, M Nakashima, T Watanabe.   

Abstract

A monoclonal antibody (mAb) TP-3 has been established by immunizing rats with the BALB/c mouse thymic epithelial cell line TEL-2. The TP-3 antigen is expressed on stroma cells of thymus, spleen, and lymph node in syngeneic BALB/c mice (H-2d). This antigen is also expressed at a low level on the cell surface of immature thymocytes, and at a high level on mature T and B cells. In allogeneic mice such as C57BL/6 (H-2b) or C3H (H-2k), no cells expressed the TP-3 antigen. Using H-2 congenic mice, reactivity with mAb TP-3 was found to map to a region of H-2DdLd or between Dd and Qa, suggesting that TP-3 is a major histocompatibility complex (MHC) class I antigen. However, immunoprecipitation analysis indicated that this antigen is not identical to the classical mouse class I molecules in terms of molecular size, antigenicity, and tissue distribution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999349     DOI: 10.1007/bf00210822

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

1.  Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage.

Authors:  B J Fowlkes; R H Schwartz; D M Pardoll
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

2.  The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.

Authors:  A M Pullen; P Marrack; J W Kappler
Journal:  Nature       Date:  1988-10-27       Impact factor: 49.962

3.  Normal thymic cortical epithelial cells developmentally regulate the expression of a B-lineage transformation-associated antigen.

Authors:  B Adkins; G F Tidmarsh; I L Weissman
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  A third class I major histocompatibility complex antigen encoded by a gene in the D region of the H-2d haplotype recognized by cytotoxic T lymphocytes.

Authors:  D W Mann; J Forman
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary relationships to H-2 genes from four other mouse strains.

Authors:  S Watts; J M Vogel; W D Harriman; T Itoh; H J Stauss; R S Goodenow
Journal:  J Immunol       Date:  1987-12-01       Impact factor: 5.422

6.  Intrathymic deletion of self-reactive cells prevented by neonatal anti-CD4 antibody treatment.

Authors:  H R MacDonald; H Hengartner; T Pedrazzini
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

Review 7.  Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex.

Authors:  J W Kappler; U Staerz; J White; P C Marrack
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

8.  Studies of two antigenic forms of Ld with disparate beta 2-microglobulin (beta 2m) associations suggest that beta 2m facilitate the folding of the alpha 1 and alpha 2 domains during de novo synthesis.

Authors:  T H Hansen; N B Myers; D R Lee
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

9.  The T cell receptor V beta 6 domain imparts reactivity to the Mls-1a antigen.

Authors:  O Kanagawa; E Palmer; J Bill
Journal:  Cell Immunol       Date:  1989-04-01       Impact factor: 4.868

10.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  2 in total

1.  Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; T Muramoto; S Mohri; K Doh-Ura; J Tateishi
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease.

Authors:  T Muramoto; T Kitamoto; J Tateishi; I Goto
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.